메뉴 건너뛰기




Volumn 157, Issue 5, 2007, Pages 1067-1068

Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin [16]

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CYCLOSPORIN A; DEOXYCHOLIC ACID; EFALIZUMAB; FLUCONAZOLE; FLUCYTOSINE; HYDROXYUREA; METHOTREXATE;

EID: 35348918394     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08171.x     Document Type: Letter
Times cited : (19)

References (9)
  • 1
    • 27744466915 scopus 로고    scopus 로고
    • Incidence of infection during efalizumab therapy for psoriasis: Analysis of the clinical trial experience
    • Langley RG, Carey WP, Rafal ES et al. Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience. Clin Ther 2005 27:1317 28.
    • (2005) Clin Ther , vol.27 , pp. 1317-28
    • Langley, R.G.1    Carey, W.P.2    Rafal, E.S.3
  • 3
    • 33646589648 scopus 로고    scopus 로고
    • The long-term efficacy and safety of new biological therapies for psoriasis
    • Papp KA. The long-term efficacy and safety of new biological therapies for psoriasis. Arch Dermatol Res 2006 298:7 15.
    • (2006) Arch Dermatol Res , vol.298 , pp. 7-15
    • Papp, K.A.1
  • 4
    • 33646167222 scopus 로고    scopus 로고
    • Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial
    • Papp KA, Bressinck R, Fretzin S et al. Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial. Int J Dermatol 2006 45:605 14.
    • (2006) Int J Dermatol , vol.45 , pp. 605-14
    • Papp, K.A.1    Bressinck, R.2    Fretzin, S.3
  • 5
    • 25444497016 scopus 로고    scopus 로고
    • Infections associated with tumor necrosis factor-alpha antagonists
    • Crum NF, Lederman ER, Wallace MR. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 2005 84:291 302.
    • (2005) Medicine (Baltimore) , vol.84 , pp. 291-302
    • Crum, N.F.1    Lederman, E.R.2    Wallace, M.R.3
  • 6
    • 0035451420 scopus 로고    scopus 로고
    • Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
    • Pappas PG, Perfect JR, Cloud GA et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001 33:690 9.
    • (2001) Clin Infect Dis , vol.33 , pp. 690-9
    • Pappas, P.G.1    Perfect, J.R.2    Cloud, G.A.3
  • 7
    • 17144388751 scopus 로고    scopus 로고
    • Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial
    • Leonardi CL, Papp KA, Gordon KB et al. Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol 2005 52:425 33.
    • (2005) J Am Acad Dermatol , vol.52 , pp. 425-33
    • Leonardi, C.L.1    Papp, K.A.2    Gordon, K.B.3
  • 8
    • 15744387890 scopus 로고    scopus 로고
    • Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis
    • Gottlieb AB, Gordon KB, Lebwohl MG et al. Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. J Drugs Dermatol 2004 3:614 24.
    • (2004) J Drugs Dermatol , vol.3 , pp. 614-24
    • Gottlieb, A.B.1    Gordon, K.B.2    Lebwohl, M.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.